{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:25:35Z","timestamp":1792517135039,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24162-w","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:00:05Z","timestamp":1762516805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Insights from integrated covalent docking and molecular dynamics simulations of nirmatrelvir analogs as potential SARS-CoV-2 Mpro inhibitors"],"prefix":"10.1038","volume":"15","author":[{"given":"Mahmoud A. A.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M. A.","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa G. M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa H. M.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshuo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Shoeib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badr","family":"Aldahmash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"24162_CR1","doi-asserted-by":"publisher","first-page":"105948","DOI":"10.1016\/j.ijantimicag.2020.105948","volume":"55","author":"L Wang","year":"2020","unstructured":"Wang, L., Wang, Y., Ye, D. & Liu, Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int. J. Antimicrob. Agents. 55, 105948. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105948 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"24162_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.23750\/abm.v91i1.9397","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta, D., Vanelli, M. W. H. O. & Declares COVID-19 a pandemic. Acta Biomed. 91, 157\u2013160. https:\/\/doi.org\/10.23750\/abm.v91i1.9397 (2020).","journal-title":"Acta Biomed."},{"key":"24162_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/10408363.2020.1783198","volume":"57","author":"M Ciotti","year":"2020","unstructured":"Ciotti, M. et al. The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci. 57, 365\u2013388. https:\/\/doi.org\/10.1080\/10408363.2020.1783198 (2020).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"24162_CR4","unstructured":"World Health Organization. (2020)."},{"key":"24162_CR5","doi-asserted-by":"publisher","unstructured":"Krishnamoorthy, S., Swain, B., Verma, R. S., Gunthe, S. S. & SARS-CoV, M. E. R. S. C. V. and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease 31, 411\u2013423, (2020). https:\/\/doi.org\/10.1007\/s13337-020-00632-9","DOI":"10.1007\/s13337-020-00632-9"},{"key":"24162_CR6","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.apsb.2022.09.011","volume":"13","author":"B Tu","year":"2023","unstructured":"Tu, B., Gao, Y., An, X., Wang, H. & Huang, Y. Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharm. Sin B. 13, 1828\u20131846. https:\/\/doi.org\/10.1016\/j.apsb.2022.09.011 (2023).","journal-title":"Acta Pharm. Sin B"},{"key":"24162_CR7","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","volume":"21","author":"K Anand","year":"2002","unstructured":"Anand, K. et al. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J. 21, 3213\u20133224. https:\/\/doi.org\/10.1093\/emboj\/cdf327 (2002).","journal-title":"EMBO J."},{"key":"24162_CR8","doi-asserted-by":"publisher","unstructured":"Yang, H. et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA 100, 13190\u201313195, (2003). https:\/\/doi.org\/10.1073\/pnas.1835675100","DOI":"10.1073\/pnas.1835675100"},{"key":"24162_CR9","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1080\/07391102.2020.1791958","volume":"39","author":"MAA Ibrahim","year":"2021","unstructured":"Ibrahim, M. A. A., Abdelrahman, A. H. M. & Hegazy, M. F. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J. Biomol. Struct. Dyn. 39, 5756\u20135767. https:\/\/doi.org\/10.1080\/07391102.2020.1791958 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"24162_CR10","doi-asserted-by":"publisher","unstructured":"Ibrahim, M. A. A. et al. In silico evaluation of prospective anti-COVID-19 drug candidates as potential SARS-CoV-2 main protease inhibitors. Protein J. 40, 296\u2013309, (2021). https:\/\/doi.org\/10.1007\/s10930-020-09945-6","DOI":"10.1007\/s10930-020-09945-6"},{"key":"24162_CR11","doi-asserted-by":"publisher","first-page":"148553","DOI":"10.1016\/j.gene.2024.148553","volume":"922","author":"A Chakraborty","year":"2024","unstructured":"Chakraborty, A. et al. Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: an in-silico perspective. Gene 922, 148553. https:\/\/doi.org\/10.1016\/j.gene.2024.148553 (2024).","journal-title":"Gene"},{"key":"24162_CR12","doi-asserted-by":"publisher","first-page":"781039","DOI":"10.3389\/fmolb.2022.781039","volume":"9","author":"S Piplani","year":"2022","unstructured":"Piplani, S., Singh, P., Petrovsky, N. & Winkler, D. A. Computational repurposing of drugs and natural products against SARS-CoV-2 main protease (M(pro)) as potential COVID-19 therapies. Front. Mol. Biosci. 9, 781039. https:\/\/doi.org\/10.3389\/fmolb.2022.781039 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"24162_CR13","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41598-025-86016-9","volume":"15","author":"G Sharma","year":"2025","unstructured":"Sharma, G. et al. Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis. Sci. Rep. 15, 2830. https:\/\/doi.org\/10.1038\/s41598-025-86016-9 (2025).","journal-title":"Sci. Rep."},{"key":"24162_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fddsv.2022.1082065","volume":"2","author":"DN Prada Gori","year":"2023","unstructured":"Prada Gori, D. N. et al. Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease. Front. Drug Discov. 2, 1. https:\/\/doi.org\/10.3389\/fddsv.2022.1082065 (2023).","journal-title":"Front. Drug Discov"},{"key":"24162_CR15","doi-asserted-by":"publisher","first-page":"105984","DOI":"10.1016\/j.ijantimicag.2020.105984","volume":"56","author":"AY Pawar","year":"2020","unstructured":"Pawar, A. Y. Combating devastating COVID-19 by drug repurposing. Int. J. Antimicrob. Agents. 56, 105984. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105984 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"24162_CR16","doi-asserted-by":"publisher","first-page":"100719","DOI":"10.1016\/j.drup.2020.100719","volume":"53","author":"S Drozdzal","year":"2020","unstructured":"Drozdzal, S. et al. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist. Updat. 53, 100719. https:\/\/doi.org\/10.1016\/j.drup.2020.100719 (2020).","journal-title":"Drug Resist. Updat"},{"key":"24162_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/1061186X.2022.2119243","volume":"31","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Progress in research and development of Temozolomide brain-targeted preparations: a review. J. Drug Target. 31, 119\u2013133. https:\/\/doi.org\/10.1080\/1061186X.2022.2119243 (2023).","journal-title":"J. Drug Target."},{"key":"24162_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0140-6736(21)02657-X","volume":"399","author":"J Heskin","year":"2022","unstructured":"Heskin, J. et al. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet 399, 21\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(21)02657-X (2022).","journal-title":"Lancet"},{"key":"24162_CR19","unstructured":"Administration, U. F. D. Fact sheet for healthcare providers: emergency use authorization for Paxlovid. 5 (2022)."},{"key":"24162_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.advms.2022.10.001","volume":"68","author":"AA Dawood","year":"2023","unstructured":"Dawood, A. A. The efficacy of paxlovid against COVID-19 is the result of the tight molecular Docking between M(pro) and antiviral drugs (nirmatrelvir and ritonavir). Adv. Med. Sci. 68, 1\u20139. https:\/\/doi.org\/10.1016\/j.advms.2022.10.001 (2023).","journal-title":"Adv. Med. Sci."},{"key":"24162_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.47287\/cen-09913-scicon3","volume":"99","author":"B Halford","year":"2021","unstructured":"Halford, B. Pfizer unveils its oral SARS-CoV-2 inhibitor. Chem. Eng. News. 99, 7\u20137 (2021).","journal-title":"Chem. Eng. News"},{"key":"24162_CR22","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen, D. R. et al. An oral SARS-CoV-2\u00a0M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science 374, 1586\u20131593. https:\/\/doi.org\/10.1126\/science.abl4784 (2021).","journal-title":"Science"},{"key":"24162_CR23","doi-asserted-by":"publisher","first-page":"24317","DOI":"10.1039\/c8cp03320j","volume":"20","author":"AM Dos Santos","year":"2018","unstructured":"Dos Santos, A. M. et al. Experimental study and computational modelling of Cruzain cysteine protease Inhibition by dipeptidyl nitriles. Phys. Chem. Chem. Phys. 20, 24317\u201324328. https:\/\/doi.org\/10.1039\/c8cp03320j (2018).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"24162_CR24","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.1039\/d1cc03953a","volume":"57","author":"CA Ramos-Guzman","year":"2021","unstructured":"Ramos-Guzman, C. A., Ruiz-Pernia, J. J. & Tunon, I. Computational simulations on the binding and reactivity of a nitrile inhibitor of the SARS-CoV-2 main protease. ChemComm 57, 9096\u20139099. https:\/\/doi.org\/10.1039\/d1cc03953a (2021).","journal-title":"ChemComm"},{"key":"24162_CR25","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00044-022-02951-6","volume":"31","author":"RP Joyce","year":"2022","unstructured":"Joyce, R. P., Hu, V. W. & Wang, J. The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with Ritonavir to reduce COVID-19-related hospitalizations. Med. Chem. Res. 31, 1637\u20131646. https:\/\/doi.org\/10.1007\/s00044-022-02951-6 (2022).","journal-title":"Med. Chem. Res."},{"key":"24162_CR26","doi-asserted-by":"publisher","first-page":"e0201321","DOI":"10.1128\/jvi.02013-21","volume":"96","author":"J Li","year":"2022","unstructured":"Li, J. et al. Structural basis of the main proteases of coronavirus bound to drug candidate PF-07321332. J. Virol. 96, e0201321. https:\/\/doi.org\/10.1128\/jvi.02013-21 (2022).","journal-title":"J. Virol."},{"key":"24162_CR27","doi-asserted-by":"publisher","first-page":"W368","DOI":"10.1093\/nar\/gki464","volume":"33","author":"JC Gordon","year":"2005","unstructured":"Gordon, J. C. et al. H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res. 33, W368\u2013W371. https:\/\/doi.org\/10.1093\/nar\/gki464 (2005).","journal-title":"Nucleic Acids Res."},{"key":"24162_CR28","unstructured":"OMEGA 4.1.1.0. OpenEye Scientific Software, Santa Fe, NM, USA, (2021)."},{"key":"24162_CR29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/ci100031x","volume":"50","author":"PC Hawkins","year":"2010","unstructured":"Hawkins, P. C., Skillman, A. G., Warren, G. L., Ellingson, B. A. & Stahl, M. T. Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database. J. Chem. Inf. Model. 50, 572\u2013584. https:\/\/doi.org\/10.1021\/ci100031x (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"24162_CR30","unstructured":"SZYBKI 2.4.0.0. OpenEye Scientific Software, Santa Fe, NM, USA, (2021)."},{"key":"24162_CR31","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","volume":"36","author":"J Gasteiger","year":"1980","unstructured":"Gasteiger, J. & Marsili, M. Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36, 3219\u20133228. https:\/\/doi.org\/10.1016\/0040-4020(80)80168-2 (1980).","journal-title":"Tetrahedron"},{"key":"24162_CR32","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nchembio.1666","volume":"10","author":"N London","year":"2014","unstructured":"London, N. et al. Covalent Docking of large libraries for the discovery of chemical probes. Nat. Chem. Biol. 10, 1066\u20131072. https:\/\/doi.org\/10.1038\/nchembio.1666 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"24162_CR33","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256 (2009).","journal-title":"J. Comput. Chem."},{"key":"24162_CR34","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli, S. et al. Computational protein-ligand Docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 11, 905\u2013919. https:\/\/doi.org\/10.1038\/nprot.2016.051 (2016).","journal-title":"Nat. Protoc."},{"key":"24162_CR35","unstructured":"AMBER. (University of California, San Francisco, 2020). (2020)."},{"key":"24162_CR36","doi-asserted-by":"publisher","first-page":"150856","DOI":"10.1016\/j.bbrc.2024.150856","volume":"735","author":"MAA Ibrahim","year":"2024","unstructured":"Ibrahim, M. A. A. et al. Exploring marine natural products for identifying putative candidates as EBNA1 inhibitors: an insight from molecular docking, molecular dynamics, and DFT computations. Biochem. Biophys. Res. Commun. 735, 150856. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150856 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"24162_CR37","doi-asserted-by":"publisher","first-page":"e0314422","DOI":"10.1371\/journal.pone.0314422","volume":"19","author":"MAA Ibrahim","year":"2024","unstructured":"Ibrahim, M. A. A. et al. Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: covalent docking, validation, and molecular dynamics simulations. PLoS One. 19, e0314422. https:\/\/doi.org\/10.1371\/journal.pone.0314422 (2024).","journal-title":"PLoS One"},{"key":"24162_CR38","doi-asserted-by":"publisher","first-page":"108997","DOI":"10.1016\/j.jmgm.2025.108997","volume":"137","author":"KAA Abdeljawaad","year":"2025","unstructured":"Abdeljawaad, K. A. A. et al. Potential P-glycoprotein (P-gp) inhibitors from SuperDRUG2 database toward reversing multidrug resistance in cancer treatment: database mining, molecular dynamics, and binding energy estimations. J. Mol. Graph Model. 137, 108997. https:\/\/doi.org\/10.1016\/j.jmgm.2025.108997 (2025).","journal-title":"J. Mol. Graph Model."},{"key":"24162_CR39","doi-asserted-by":"publisher","unstructured":"Mahmoud, D. G. M., Mekhemer, G. A. H., Hegazy, M. E. F., Al-Fahemi, J. H. & Ibrahim, M. A. A. In-Silico exploration of the streptomedb database for potential irreversible DprE1 inhibitors toward antitubercular treatment. Chemistryopen n\/a. 2500237 https:\/\/doi.org\/10.1002\/open.202500237 (2025).","DOI":"10.1002\/open.202500237"},{"key":"24162_CR40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035 (2004).","journal-title":"J. Comput. Chem."},{"key":"24162_CR41","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713. https:\/\/doi.org\/10.1021\/acs.jctc.5b00255 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"24162_CR42","doi-asserted-by":"publisher","first-page":"9620","DOI":"10.1021\/ja00074a030","volume":"115","author":"WD Cornell","year":"2002","unstructured":"Cornell, W. D., Cieplak, P., Bayly, C. I. & Kollman, P. A. Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation. J. Am. Chem. Soc. 115, 9620\u20139631. https:\/\/doi.org\/10.1021\/ja00074a030 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"24162_CR43","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh ewald: AnN\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092. https:\/\/doi.org\/10.1063\/1.464397 (1993).","journal-title":"J. Chem. Phys."},{"key":"24162_CR44","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690. https:\/\/doi.org\/10.1063\/1.448118 (1984).","journal-title":"J. Chem. Phys."},{"key":"24162_CR45","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto, S. & Kollman, P. A. Settle - an analytical version of the shake and rattle algorithm for rigid water models. J. Comput. Chem. 13, 952\u2013962. https:\/\/doi.org\/10.1002\/jcc.540130805 (1992).","journal-title":"J. Comput. Chem."},{"key":"24162_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/cphc.201200799","volume":"14","author":"P Politzer","year":"2013","unstructured":"Politzer, P. & Murray, J. S. Halogen bonding: an interim discussion. ChemPhysChem 14, 278\u2013294. https:\/\/doi.org\/10.1002\/cphc.201200799 (2013).","journal-title":"ChemPhysChem"},{"key":"24162_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","volume":"18","author":"I Massova","year":"2000","unstructured":"Massova, I. & Kollman, P. A. Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding. Perspect. Drug Discov. 18, 113\u2013135. https:\/\/doi.org\/10.1023\/A:1008763014207 (2000).","journal-title":"Perspect. Drug Discov"},{"key":"24162_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev, A., Bashford, D. & Case, D. A. Exploring protein native States and large-scale conformational changes with a modified generalized born model. Proteins 55, 383\u2013394. https:\/\/doi.org\/10.1002\/prot.20033 (2004).","journal-title":"Proteins"},{"key":"24162_CR49","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jcc.21666","volume":"32","author":"T Hou","year":"2011","unstructured":"Hou, T., Wang, J., Li, Y. & Wang, W. Assessing the performance of the molecular mechanics\/Poisson Boltzmann surface area and molecular mechanics\/generalized born surface area methods. II. The accuracy of ranking poses generated from Docking. J. Comput. Chem. 32, 866\u2013877. https:\/\/doi.org\/10.1002\/jcc.21666 (2011).","journal-title":"J. Comput. Chem."},{"key":"24162_CR50","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem. Rev. 119, 9478\u20139508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055 (2019).","journal-title":"Chem. Rev."},{"key":"24162_CR51","doi-asserted-by":"publisher","first-page":"14450","DOI":"10.1039\/c7cp07623a","volume":"20","author":"H Sun","year":"2018","unstructured":"Sun, H. et al. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches. Phys. Chem. Chem. Phys. 20, 14450\u201314460. https:\/\/doi.org\/10.1039\/c7cp07623a (2018).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"24162_CR52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1109\/34.908974","volume":"23","author":"AM Mart\u00ecnez","year":"2001","unstructured":"Mart\u00ecnez, A. M. & Kak, A. C. PCA versus LDA. IEEE Trans. Pattern Anal. Mach. Intell. 23, 228\u2013233. https:\/\/doi.org\/10.1109\/34.908974 (2001).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"24162_CR53","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1021\/jm011027b","volume":"45","author":"M Brustle","year":"2002","unstructured":"Brustle, M. et al. Descriptors, physical properties, and drug-likeness. J. Med. Chem. 45, 3345\u20133355. https:\/\/doi.org\/10.1021\/jm011027b (2002).","journal-title":"J. Med. Chem."},{"key":"24162_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s1359-6446(99)01451-8","volume":"5","author":"DE Clark","year":"2000","unstructured":"Clark, D. E. & Pickett, S. D. Computational methods for the prediction of \u2018drug-likeness\u2019. Drug Discov Today. 5, 49\u201358. https:\/\/doi.org\/10.1016\/s1359-6446(99)01451-8 (2000).","journal-title":"Drug Discov Today"},{"key":"24162_CR55","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. PkCSM: predicting Small-Molecule Pharmacokinetic and toxicity properties using Graph-Based signatures. J. Med. Chem. 58, 4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104 (2015).","journal-title":"J. Med. Chem."},{"key":"24162_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.2174\/1381612823666170711112510","volume":"24","author":"J da Silva Costa","year":"2018","unstructured":"da Silva Costa, J. et al. Virtual screening and statistical analysis in the design of new caffeine analogues molecules with potential epithelial anticancer activity. Curr. Pharm. Des. 24, 576\u2013594. https:\/\/doi.org\/10.2174\/1381612823666170711112510 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"24162_CR57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/ci800293n","volume":"49","author":"KE Hevener","year":"2009","unstructured":"Hevener, K. E. et al. Validation of molecular Docking programs for virtual screening against dihydropteroate synthase. J. Chem. Inf. Model. 49, 444\u2013460. https:\/\/doi.org\/10.1021\/ci800293n (2009).","journal-title":"J. Chem. Inf. Model."},{"key":"24162_CR58","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cbpa.2007.08.033","volume":"11","author":"C McInnes","year":"2007","unstructured":"McInnes, C. Virtual screening strategies in drug discovery. Curr. Opin. Chem. Biol. 11, 494\u2013502. https:\/\/doi.org\/10.1016\/j.cbpa.2007.08.033 (2007).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"24162_CR59","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nrd941","volume":"1","author":"F Bajorath","year":"2002","unstructured":"Bajorath, F. Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov. 1, 882\u2013894. https:\/\/doi.org\/10.1038\/nrd941 (2002).","journal-title":"Nat. Rev. Drug Discov"},{"key":"24162_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jpha.2022.10.005","volume":"13","author":"W Chen","year":"2023","unstructured":"Chen, W. et al. Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection. J. Pharm. Anal. 13, 255\u2013261. https:\/\/doi.org\/10.1016\/j.jpha.2022.10.005 (2023).","journal-title":"J. Pharm. Anal."},{"key":"24162_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00894-012-1563-4","volume":"19","author":"A Wolf","year":"2013","unstructured":"Wolf, A. & Kirschner, K. N. Principal component and clustering analysis on molecular dynamics data of the ribosomal L11.23S subdomain. J. Mol. Model. 19, 539\u2013549. https:\/\/doi.org\/10.1007\/s00894-012-1563-4 (2013).","journal-title":"J. Mol. Model."},{"key":"24162_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S. & Hopkins, A. L. Quantifying the chemical beauty of drugs. Nat. Chem. 4, 90\u201398. https:\/\/doi.org\/10.1038\/nchem.1243 (2012).","journal-title":"Nat. Chem."},{"key":"24162_CR63","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1016\/j.ejmech.2010.07.069","volume":"45","author":"MA Bakht","year":"2010","unstructured":"Bakht, M. A., Yar, M. S., Abdel-Hamid, S. G., Qasoumi, A., Samad, A. & S. I. & Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives. Eur. J. Med. Chem. 45, 5862\u20135869. https:\/\/doi.org\/10.1016\/j.ejmech.2010.07.069 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"24162_CR64","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrd.2018.197","volume":"17","author":"A Mullard","year":"2018","unstructured":"Mullard, A. Re-assessing the rule of 5, two decades on. Nat. Rev. Drug Discov. 17, 777\u2013777. https:\/\/doi.org\/10.1038\/nrd.2018.197 (2018).","journal-title":"Nat. Rev. Drug Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24162-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24162-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24162-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:00:07Z","timestamp":1762516807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24162-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24162"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24162-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"39099"}}